Fusco A - Search Results

1

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.

De Martino M, Esposito F, Capone M, Pallante P, Fusco A. De Martino M, et al. Among authors: fusco a. Cancers (Basel). 2022 Jun 23;14(13):3079. doi: 10.3390/cancers14133079. Cancers (Basel). 2022. PMID: 35804851 Free PMC article. Review.

2

Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2.

Pentimalli F, Dentice M, Fedele M, Pierantoni GM, Cito L, Pallante P, Santoro M, Viglietto G, Dal Cin P, Fusco A. Pentimalli F, et al. Among authors: fusco a. Cancer Res. 2003 Nov 1;63(21):7423-7. Cancer Res. 2003. PMID: 14612541 Retracted.

3

High mobility group A1 expression correlates with the histological grade of human glial tumors.

Donato G, Martinez Hoyos J, Amorosi A, Maltese L, Lavano A, Volpentesta G, Signorelli F, Pentimalli F, Pallante P, Ferraro G, Tucci L, Signorelli CD, Viglietto G, Fusco A. Donato G, et al. Among authors: fusco a. Oncol Rep. 2004 Jun;11(6):1209-13. Oncol Rep. 2004. PMID: 15138557

4

The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.

Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P, Martelli ML, Trapasso F, Chiariotti L, Fusco A. Iuliano R, et al. Among authors: fusco a. Oncogene. 2004 Nov 4;23(52):8432-8. doi: 10.1038/sj.onc.1207766. Oncogene. 2004. PMID: 15378013

5

A differential proteomic approach to identify proteins associated with thyroid cell transformation.

Paron I, D'Ambrosio C, Scaloni A, Berlingieri MT, Pallante PL, Fusco A, Bivi N, Tell G, Damante G. Paron I, et al. Among authors: fusco a. J Mol Endocrinol. 2005 Feb;34(1):199-207. doi: 10.1677/jme.1.01618. J Mol Endocrinol. 2005. PMID: 15691888

6

UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.

Pallante P, Berlingieri MT, Troncone G, Kruhoffer M, Orntoft TF, Viglietto G, Caleo A, Migliaccio I, Decaussin-Petrucci M, Santoro M, Palombini L, Fusco A. Pallante P, et al. Among authors: fusco a. Br J Cancer. 2005 Aug 22;93(4):464-71. doi: 10.1038/sj.bjc.6602721. Br J Cancer. 2005. PMID: 16106252 Free PMC article.

7

High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.

Pierantoni GM, Finelli P, Valtorta E, Giardino D, Rodeschini O, Esposito F, Losa M, Fusco A, Larizza L. Pierantoni GM, et al. Among authors: fusco a. Endocr Relat Cancer. 2005 Dec;12(4):867-74. doi: 10.1677/erc.1.01049. Endocr Relat Cancer. 2005. PMID: 16322327

8

High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.

Pierantoni GM, Rinaldo C, Esposito F, Mottolese M, Soddu S, Fusco A. Pierantoni GM, et al. Among authors: fusco a. Cell Death Differ. 2006 Sep;13(9):1554-63. doi: 10.1038/sj.cdd.4401839. Epub 2005 Dec 9. Cell Death Differ. 2006. PMID: 16341121 Retracted.

9

MicroRNA deregulation in human thyroid papillary carcinomas.

Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A. Pallante P, et al. Among authors: fusco a. Endocr Relat Cancer. 2006 Jun;13(2):497-508. doi: 10.1677/erc.1.01209. Endocr Relat Cancer. 2006. PMID: 16728577

10

HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.

Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C, Melillo RM, Helin K, Croce CM, Fusco A. Fedele M, et al. Among authors: fusco a. Cancer Cell. 2006 Jun;9(6):459-71. doi: 10.1016/j.ccr.2006.04.024. Cancer Cell. 2006. PMID: 16766265 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,126 results

Search Page